The risk-reward nexus in the innovation-inequality relationship: who takes the risks? Who gets the rewards?
Summary (3 min read)
1. Introduction
- Inequality has hit the front pages, not only because it has been increasing, but also because of a seemingly inexorable concentration of income at the top of the distribution through boom and bust (OECD, 2008).
- By embedding their analysis in the collective, cumulative, and uncertain characteristics of the innovation process, the authors can ask who contributes labor and capital to the process and who reaps the financial rewards from it.
- And, as the authors will argue below, to understand this process, it is fundamental not to confuse value that is created in organizations with value that is extracted through “markets”.
- In Section 2, the authors lay out the conceptual foundations for understanding how innovation may be related to inequality by focusing on its core characteristics -- the collective, cumulative, and uncertain character of the innovation process.
3. The Risk-Reward Nexus
- The cumulative character of the innovation process creates a time-lag between the bearing of risk and the generation of returns that can enable some economic actors to “position” themselves strategically in order to extract more value from the returns to the innovation process than the “value-added” that their contributions of labor and capital create.
- From this perspective, the agency-theory argument that shareholders are the only economic actors who invest in the economy without a guaranteed return may serve as an ideology for those who claim to be representing the interests of public shareholders to appropriate returns that, on the basis of risk-taking, should be distributed to taxpayers and workers.
- The State can allocate these gains to support innovation through infrastructural investments or through subsidies to businesses and households designed to encourage innovation.
- But in the subsequent economic decline, in part induced, the authors would argue, by the success of the 13 value-extractors in concentrating returns in their own hands, workers and taxpayers typically lose out permanently even as the value-extractors use their control over corporate resource allocation to continue to look for ways to consolidate their gains.
4. Financial Actors and Value Extraction
- Well-developed markets in inputs and outputs can enhance the ability of the possessors of capital and labor to extract value.
- Rather than income being distributed equitably (which of course does not necessarily mean equally) according to the value that different economic actors create, certain types of economic actors are able to make use of both the reality and ideology of markets to extract disproportionate amounts of value for themselves.
- Financial deregulation and the spread of stock-related pay have enabled investors (especially of private equity) and top corporate executives to secure ownership of assets just before major innovation-related gains are capitalized into them.
- Let us give two important examples based on the U.S. experience of how this excessive value-extraction process works.
4.1 Value extraction through high-tech startups
- In October 1980 Genentech, founded in 1976 by venture capitalists and scientists, was the first dedicated biopharmaceutical company to do an IPO.
- The allocation of access to shares in an IPO favors insiders, including the Wall Street banks that underwrite the deals.,.
- The foundation for the emergence of the U.S. venture-capital model was the rise of the microelectronics industry in Silicon Valley from the late 1950s (Kenney and Florida 2000; Lazonick 2009b, ch. 2).
- Given the massive amount of funds that have flowed into the U.S. biopharmaceutical industry and the relatively small number of successful drug discoveries, the overall returns in terms of drug development have been small while financial interests, including highly remunerated biopharma executives, have, nevertheless, taken home huge sums (Lazonick and Sakinç 2010).
- At the same time, however, the average gains from exercising options of the five highest paid Microsoft executives were about 100 times that of the average gains of Microsoft employees (Lazonick 2009b, ch. 2).
4.2 Value extraction through established companies
- Unlike many other high-tech companies, the stock market was of little if any importance in inducing startup capital to back Microsoft in its early stages.
- The stock market was, however, very important for Microsoft in the 24 early 1980s to induce software engineers, computer programmers, and other technical personnel to forego secure employment opportunities with established companies like IBM, Hewlett-Packard, Motorola, and Texas Instruments to work for a still uncertain new venture.
- Given the fact that in the United States companies are not required to announce the dates on which they actually do open market repurchases of their own shares, there is an opportunity for top executives who have this information to engage in insider trading by using this information to time option exercises and stock sales (Fried 2000 and 2001).
- If the authors assume that named executives whose corporate compensation was below the $1.5 million threshold were able to augment that income by 25 percent from other sources, then the number of named executives in the top 0.1 percent in 2008 would have been 5,555 (Lazonick 2012a).
5.1 Analytical Implications
- By generating real productivity gains, innovation can potentially increase the incomes of all participants in the process.
- While SBTC makes “technical change” central to its analysis of the changing income distribution, it has no theory of innovation or even risk-taking.
- Given the growth in income inequality in the 1980s and 1990s, SBTC proponents assumed that a growing premium to collegeeducated workers was caused by the bias of the computer revolution of the time that increased the demand for the types of skills that college-educated workers have relative to less educated members of the labor force.
- The RRN approach argues that organizations generate innovation, and that because of the collective, cumulative and uncertain character of the innovation process, certain economic actors can, by gaining control over the allocation of resources within these organizations, appropriate rewards from the innovation process that are disproportionate from the risks that they took in that process.
- The SBTC approach argues that markets determine both the diffusion of technology and the returns to different types of labor, with the skill-biased characteristics of that technology affecting the demand for labor with different types of skills.
5.2 Policy Implications
- The policy agenda that flows from the Risk-Reward Nexus approach is fundamentally different from that which arises from a “market failure” understanding of inequality (such as the one embedded in the SBTC approach).
- Indeed by focusing on the risk-reward nexus in the innovation process, the authors believe the economic system will perform better and generate more tax receipts that can then be used by the State for such retraining purposes for existing technologies as well as investing in the next round of new technologies.
- In the U.S. case, the sums that could be diverted from buybacks are significant: about $2.6 trillion for 459 S&P 500 companies over the past decade, representing about 54 percent of net income.
- And rather than creating myths around certain actors (the hyping up of VC or SMEs), it is fundamental to recognize the stages at which the actors are important, along the risk space.
Did you find this useful? Give us your feedback
Citations
925 citations
471 citations
449 citations
400 citations
367 citations
References
49,666 citations
14,368 citations
14,045 citations
12,469 citations
11,095 citations
"The risk-reward nexus in the innova..." refers background in this paper
...Going even further in eliminating Knightian uncertainty from economic analysis, endogenous growth theory assumes that R&D can be modeled as a lottery, in which one can calculate the probability of “getting lucky” (Romer, 1990)....
[...]
Related Papers (5)
Frequently Asked Questions (14)
Q2. How do the banks encourage a run-up in stock prices?
By keeping the float small, under-pricing the stock issue, and hyping the stock, the banks encourage a post-IPO run-up in stock prices as the investing public clamors for the listed shares.
Q3. What is the importance of innovation in the economic agenda?
the importance of ‘intangible’ capital (patents, copyrights, design) appears on nearly every government’s growth agenda, as well as that of transnational 35organizations (OECD, 2012).
Q4. What is the effect of the cumulative character of the innovation process?
The cumulative character of the innovation process creates a time-lag between the bearing of risk and the generation of returns that can enable some economic actors to “position” themselves strategically in order to extract more value from the returns to the innovation process than the “value-added” that their contributions of labor and capital create.
Q5. How much of the company’s net income was paid out as dividends?
In addition the company paid out 49 percent of its net income as dividends, thus distributing a total of 138 percent of its net income to shareholders over the decade.
Q6. What is the common reason for speculators to buy and sell stock?
including hedge funds, are willing to buy and sell on news about R&D contracts won or cancelled and clinical trials that succeed or fail.
Q7. What were the first military technologies that were commercialized?
Military technologies that were later commercialized were developed by tens of thousands of scientists, engineers, and other technical personnel in research labs of larger ICT companies including AT&T, General Electric, IBM, Sylvania, Xerox, Motorola, and Texas Instruments.
Q8. What is the main reason for the failure of the OECD to curb bank bonuses?
the battle against increasing inequality has had little success, as witnessed in the failed attempt to curb bank bonuses after the 2008-2009 financial crisis.
Q9. When was the first dedicated biopharmaceutical company to do an IPO?
In October 1980 Genentech, founded in 1976 by venture capitalists and scientists, was the first dedicated biopharmaceutical company to do an IPO.
Q10. Why has inequality hit the front pages?
Inequality has hit the front pages, not only because it has been increasing, but also because of a seemingly inexorable concentration of income at the top of the distribution through boom and bust (OECD, 2008).
Q11. What is the argument that shareholders are the only economic actors who invest in the economy without a?
From this perspective, the agency-theory argument that shareholders are the only economic actors who invest in the economy without a guaranteed return may serve as an ideology for those who claim to be representing the interests of public shareholders to appropriate returns that, on the basis of risk-taking, should be distributed to taxpayers and workers.
Q12. What is the RRN framework for analyzing the innovation-inequality dynamic?
In Section 2, the authors lay out the conceptual foundations for understanding how innovation may be related to inequality by focusing on its core characteristics -- the collective, cumulative, and uncertain character of the innovation process.
Q13. How long does it take to produce a biopharma drug?
But it typically requires at least twice that amount of time to generate a biopharma drug that, having gone through phase 1, 2, and 3 clinical trials, the U.S. Food and Drug Administration may deem effective and safe enough to market.
Q14. What is the reason why the biopharmaceutical industry has not been very productive?
Yet for all this government spending and the business funding that has flowed into the biopharmaceutical industry through private equity (including venture capital), IPOs, secondary stock issues, and R&D contracts, the biopharmaceutical industry has not been very productive (Demirel and Mazzucato, 2012; Pisano 2006).